In May 2010, the Board agreed to establish a Genetic Modification Advisory Committee (GMAC) to provide scientific, technical, and other advice related to biosafety to the Minister or the Board. The role of this committee includes the identification of risks related to the use of LMO or products containing LMO.
EN 
MS